Skip to content

ArisGlobal Blogs

Categories
Blog: Automation in ICSR Processing – Is Artificial Intelligence the Paradigm Shift in Pharmacovigilance?

Artificial intelligence (AI), machine learning, deep learning, natural language processing – in short, cognitive computing, is changing the pharmacovigilance world…

Learn More
Breaking Down Silos across the Life Sciences Enterprise Helps Drive Innovation

Silos have long plagued the life sciences industry, and nowhere is this more notable than with how information and data…

Learn More

Today’s Medical Information (MI) and Medical Affairs professionals are juggling multiple challenges: they must adapt to decentralization, outsourcing and globalization…

Learn More

Safety departments at Marketing Authorization Holders & Regulatory Authorities are under pressure from all sides. They must constantly stay on…

Learn More

Rising Expectations from Regulatory Affairs Executives As we all know from experience, not all cloud solutions are the same and…

Learn More

Artificial intelligence (AI), machine learning, deep learning, natural language processing – in short, cognitive computing, is changing the pharmacovigilance world as we know it. While there’s a lot of talk about how AI will affect jobs, where it will have the most powerful impact is on the quality of work and the speed at which manual tasks can be accomplished.

Learn More

This is the last in the ArisGlobal three-part blog series on Regulatory Affairs transformation. Digitization is sweeping the life sciences industry, disrupting traditional working practices and opening doors to better ways of collaborating, tracking and sharing documents and data, and gaining clear oversight into the product supply chain.

Learn More

The life sciences industry is confronting a wave of transformational change, brought about by multiple factors, including the growth of new clinical trial markets, a rapid rise in drug development innovation, reimbursement challenges, heightened regulatory requirements and a demand for evidence-based medicine, among many others. These drivers and the resultant changes are having a profound effect on regulatory affairs.

Learn More

Regulatory affairs departments are accustomed – and even open — to change and adapting their technology and processes in response…

Learn More

If you’re in Regulatory Affairs, you know the IDMP-compliance-truck is headed your way. Which questions though are plaguing your team?…

Learn More